Indian Drug Makers Seek Relief From Price Control
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Even as drug pricing in India reaches a flashpoint between the domestic pharmaceutical industry and the government, a high-level meeting has been convened next week between the industry, the ministry of chemicals and fertilizers and the National Pharmaceutical Pricing Authority, the body that determines and regulates pricing of drugs, to chart out some remedial measures for drug makers who are currently grappling with a significant escalation in production costs